Fractional CPO Services in Ireland

Senior fractional CPO day rates in Ireland typically run €900-€1,800/day for 10+ year executives. Monthly retainers for 2-3 days per week run €5,000-€12,000/month. Health tech CPOs with CE-marked product experience command the top of the band in Galway and Dublin medtech; SaaS CPOs with product-led growth (PLG) and PLG metrics expertise carry a similar premium in Dublin fintech. By comparison, a full-time CPO in Ireland costs €140,000-€220,000 in base salary plus 11.05% employer PRSI, equity, pension contributions and benefits, totalling €185,000-€300,000 fully loaded annually (Morgan McKinley 2026 Ireland Executive Salary Guide, Marks Sattin Ireland 2025). A 2-day-per-week fractional engagement therefore represents 40-65% savings in Year 1.

Irish companies engaging fractional CPOs pay invoices as standard B2B services (deductible against corporation tax). Importantly, qualifying R&D activities performed by the fractional CPO (product roadmap engineering, algorithm research, AI feature design, technical feasibility studies) can be included as outsourced R&D expenditure under the 30% R&D tax credit (rising to 35% per Budget 2025 proposals). No employer PRSI applies when the engagement is a genuine contract for service under the Karshan framework. The fractional CPO operates through their own Limited company, retains product autonomy, can substitute other product professionals, and bears commercial risk. VAT applies at 23% on Irish-resident provider invoices.

The 30% R&D tax credit applies to qualifying scientific or technological R&D activities. Fractional CPO time billed for qualifying activities (novel product engineering, technical feasibility studies, algorithm and AI research) can be included as outsourced R&D expenditure subject to the qualifying-spend cap. Fractional CPOs also lead the IP strategy required for the Knowledge Development Box (10% effective corporation tax rate on qualifying IP profits): scoping qualifying IP, coordinating with patent attorneys, and structuring the chart of accounts for streaming qualifying income. For SaaS scale-ups with copyrighted software and biopharma companies with patented compounds, the R&D credit plus KDB stack is one of the highest-leverage CPO and CFO collaborations in Ireland.

In a typical 90-day foundation engagement (Fractionus-style), an Irish fractional CPO runs discovery on product-market fit and ICP, installs OKRs and PLG metrics (activation, retention, expansion), reviews the product roadmap and team structure, hires the first Group PM or Head of Product, and prepares the Series A or B product narrative for investors. For pre-Series-A Irish SaaS, the fractional CPO often acts as the de-facto CPO for 6-12 months, transitioning to advisory once a full-time CPO is hired post-Series B. SaaS Fractional CPO's April 2026 published guidance describes this hybrid model. For fintech and medtech, the fractional CPO additionally handles regulatory-tech roadmap (DORA, MiCA for fintech; EU MDR, IEC 62304 for medtech).

The EU AI Act has phased obligations: general-purpose AI obligations apply from August 2025, full obligations for high-risk AI systems apply from August 2026. Irish SaaS and pharma deploying AI features hire fractional CPOs to scope AI inventory across the product, classify systems against the AI Act risk tiers, design governance and human oversight controls, run conformity assessments where required, and prepare regulator-facing technical documentation. Fractional CPOs in this niche typically have prior CPO seats in AI-intensive scale-ups, and often partner with fractional General Counsel for the legal workstream. Specialist AI Act premiums are +15-30% over base fractional CPO rate.

Three demand clusters. First, SaaS (Dublin, 193 SaaS companies) is the primary buyer; fractional CPO is the natural leadership layer pre-Series B for product-market fit and roadmap reset. Second, Fintech (Dublin Class of 2026 fintechs including Wayflyer, TransferMate, Fenergo, Nomupay) needs CPO-level oversight on PSD2 and PSD3 open banking, embedded finance, and DORA-compliant product architecture. Third, MedTech and HealthTech (Galway, Dublin) deploys AI-driven medtech as highlighted in IDA 2026 overview; fractional CPOs with IEC 62304 and EU MDR product experience command top-band premium.

Product-led growth (PLG) is the dominant motion for Series A-B Dublin SaaS, with self-service onboarding, in-product activation, expansion revenue and product-qualified leads (PQLs) replacing traditional sales-led models. Fractional CPOs install PLG metrics (activation rate, time-to-value, expansion rate), redesign the free or trial tier, instrument the product analytics stack (Mixpanel, Amplitude, PostHog), build the PQL handoff to sales, and run experimentation cadence. For founders moving from sales-led to PLG, the fractional CPO usually pairs with a fractional CSO or CRO to align the GTM motion. Fractionus and SaaS Fractional CPO both publish PLG-anchored playbooks.

Irish fractional CPO engagements typically run 6-18 months, with monthly renewal options. Fractionus's 90-day foundation period is the standard starting block. Initial contracts often span 6 months tied to specific deliverables (product strategy reset, EU AI Act readiness, first PM hire, Series B product narrative). The Karshan framework favours fixed-term, deliverable-anchored engagements over open-ended retainers. Many Series A-B Dublin SaaS companies use a 6-month foundation period (building product function and team) followed by a steady-state 2 days/week retainer for ongoing strategic product leadership through to Series C or full-time CPO hire.